Main menu For students For teachers Explore our subjects Student events & courses

Explore

More for students
Sign in

Teaching Economics

In the News

Anti-competitive behaviour in market for hydrocortisone tablets

Geoff Riley

4th March 2017

Share this content:

On the surface this is a classic example of anti-competitive behaviour in a duopolistic market.

The CMA has alleged that Concordia and Actavis signed illegal agreements which enabled high prices for a life-saving drug to be prolonged. Naturally the announcement has brought a wave of criticism for the businesses involved because the cost of higher prices for drugs routinely used in the NHS are ultimately paid for by the taxpayer.

You can read more about the case here on the CMA website

Share this content:

Geoff Riley

Geoff Riley FRSA has been teaching Economics for nearly forty years. He has over twenty years experience as Head of Economics at leading schools. He writes extensively and is a contributor and presenter on CPD and Revision conferences in the UK and overseas.

@tutor2uGeoff

You might also like

In the News Teaching Activity – Does the childcare industry need regulating to reduce hidden costs to parents? (June 2026)

4th June 2026

In the News Teaching Activity – Is Live Nation-Ticketmaster abusing its monopoly power? (Apr 2026)

27th April 2026

CMA Introduces Price Caps for Vet Bills

24th March 2026

Micro Case Study: Apple

Topical case studies

Micro Case Study: Amazon

Topical case studies

UK Fuel Market: Rocket and Feather Pricing: A Case Study in Market Failure

19th March 2026

In the News Teaching Activity – Should Netflix be allowed to acquire Warner Bros? (Dec 2025)

11th December 2025

In the News Teaching Activity – what are the benefits of Kingsmill buying up Hovis? (Sept 2025)

18th September 2025